Intelligence · Clinical pipeline
Metabolic & obesity R&D Pipeline
GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.
Quick answer
Metabolic & obesity: NovaPharmaNews indexes 744 metabolic & obesity clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.
Top sponsors
- Takeda 75 programs
- NovoThirteen 61 programs
- First People's Hospital 38 programs
- Regeneron UK 35 programs
- Eli Lilly and 29 programs
- Chinese Academy of 26 programs
- United Therapeutics Europe 24 programs
- Boehringer Ingelheim 19 programs
- Anaxis Pharma 18 programs
- LEXICON PHARMACEUTICALS 16 programs
- George Institute for 15 programs
- Novo Nordisk A/S 14 programs
Pipeline programs
-
Peanuts
United Therapeutics Europe Ltd
Prediabetes
1 trial -
Phase 1 Wonderlab Product
Chongqing Precision Biotech Co., Ltd
Diabetes
1 trial -
Phentermine
Takeda
Obesity
1 trial -
Power Line Program
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Metabolic Health
1 trial -
Probiotics
Sun Yat-sen University
Cardiometabolic Risk Factors
1 trial -
Pueraria lobata radix
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Redefine
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Obesity & Overweight
1 trial -
Semaglutide
GT Biopharma
Obesity (Disorder)
1 trial -
Sniffing emotional tears
Hospital Authority, Hong Kong
Obesity
1 trial -
Study product A (Wonderlab wonder4shape)
Chongqing Precision Biotech Co., Ltd
Overweight and Obesity
1 trial -
Tests of the expression of CXCL3 in various tissues
The First People's Hospital of Lianyungang
Diabetic Kidney Disease (DKD)
1 trial -
UAEU_CMHS_TWM_IM_MODY_2022
United Therapeutics Europe Ltd
Maturity-onset Diabetes of the Young
1 trial -
UMULINE NPH
Takeda
Type 2 Diabetes
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Obesity &Amp;Amp;Amp; Overweight
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Overweight and Obesity
1 trial -
Xuebi formula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Peripheral Neuropathy
1 trial -
bitter melon peptides
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes
1 trial -
human cord blood-derived mononuclear cells (HCB-MNCs)
The First People's Hospital of Lianyungang
Refractory Diabetic Foot
1 trial -
insulin aspart
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
insulin injection 15 minutes before meals
The First People's Hospital of Lianyungang
Diabetes
1 trial -
metformin, topiramate
Hospital Authority, Hong Kong
Obesity
1 trial -
multi-factorial intervention
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
omega-3 polyunsaturated fatty acids
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
the traditional Chinese medicine prescription ' Shenzhuo Decoction '
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Kidney Disease (DKD)
1 trial
Frequently asked questions
How many metabolic & obesity pipeline programs are tracked?
744 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.